The diagnosis of a breast recurrence of lung adenocarcinoma was confirmed by molecular analysis that revealed the presence of the same EGFR mutation detected in the primary lung neoplasia (exon 19, p.E746_A750del c.2236_2250del NM_005228.4). The gene discussed is EGFR; the disease is lung adenocarcinoma.